Larotrectinib

(3S)-N-{5-[(2R)-2-(2,5-Difluorphenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl}-3-hydroxypyrrolidin-1-carboxamid

Stoffgruppe

Antineoplastisches Mittel (Proteinkinase-Inhibitor)